GL1X · GenesisL1 explorer

Research workbench

GTPase domain of septin 9 in complex with GTP-gamma-S

Analyse GTPase domain of septin 9 in complex with GTP-gamma-S in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5CYP
Type
protein
Length
940 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Septin-9
UniProt
Q9UHD8
Ligands
GSP, MG
Pockets
10 · best druggability 0.81

Structure

x-ray diffraction · 4 distinct chains · 46% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASeptin-9protein24843% helix, 18% strandQ9UHD8
BSeptin-9protein22747% helix, 18% strandQ9UHD8
CSeptin-9protein23845% helix, 18% strandQ9UHD8
DSeptin-9protein22748% helix, 19% strandQ9UHD8

Ligands and binding sites

  • GSP · 5'-guanosine-diphosphate-monothiophosphate · ligand · 4 copies · chains A, B, C, D
  • MG · Magnesium ion · metal · 4 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15170.810.8771GSP, MG
24550.780.8663GSP, MG
32830.650.8144GSP, MG
43000.640.8140GSP, MG
5730.390.7813empty

Interfaces

2 interfaces between chains.

  • A–B · 1148 Ų buried · 17 hydrogen bonds · protein-protein
  • C–D · 1034 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 5CYP · GTPase domain of Septin 9 in complex with GTP-gamma-S · the same entry in another collection · chain D against D, TM-score 1.00
  • Q9UHD8 · AlphaFold monomer V2.0 prediction for septin-9 (Q9UHD8) · a predicted model of the same protein · chain C against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.